Tag: FDA 505(b)(2)

Medication Reformulations: Why Drug Formulas Change and What It Means for Patients

Explore why pharmaceutical companies change drug formulas through medication reformulation. Learn about the FDA 505(b)(2) pathway, bioequivalence, and how these changes impact patient safety, compliance, and costs.